1
|
Schulman ML, Hayes NK, Wilson TA, Grewar JD. Immunocontraceptive Efficacy of Native Porcine Zona Pellucida (pZP) Treatment of Nevada's Virginia Range Free-Roaming Horse Population. Vaccines (Basel) 2024; 12:96. [PMID: 38250909 PMCID: PMC10820100 DOI: 10.3390/vaccines12010096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2023] [Revised: 01/07/2024] [Accepted: 01/16/2024] [Indexed: 01/23/2024] Open
Abstract
In North America, range constraints due to burgeoning development increasingly encroach on wild horse habitat and necessitate effective but humane reproductive management. The largest free-roaming wild horse fertility control program by population (>3500) and territory size (≈300,000 acres) is located within Nevada's Virginia Range. Data from a field study investigated porcine zona pellucida (pZP) immunocontraception via remote dart delivery to mares in this population. Analyses aimed to measure efficacy by treatment effects on annual birth rates and population demographics and to evaluate treatment frequency and season against these variables. Analyses included mares' monthly data (January 2019-December 2022; 48 months), characterized by cumulative vaccination numbers subset into four classifications considering the vaccine as having no loss of efficacy or a loss within a 6-, 12-, and 18-month period post vaccination; from foaling data, the likelihood of being in foal and of conceiving in that month; and from age, as mature or immature (<1 years-old). A downward foaling rate and trend in the numbers of mature mares, descriptively presented at monthly intervals, showed markedly declining annual seasonal breeding peaks, with no observed change in foaling season or duration. Within four years, population coverage surpassed 70% and was associated with a 58% reduction in foaling, with only a 10% conception rate. Vaccinated mares increased proportionally: assuming a 12-month decay rate, the system reached stability at an average ≈1.0 vaccination/mare/year, providing a robust recommendation for treatment frequency contributing to best management practices.
Collapse
Affiliation(s)
- Martin L. Schulman
- Veterinary Population Management Laboratory, Faculty of Veterinary Science, University of Pretoria, Pretoria 0110, South Africa;
| | - Nicole K. Hayes
- American Wild Horse Campaign, Davis, CA 95617, USA; (N.K.H.); (T.A.W.)
| | - Tracy A. Wilson
- American Wild Horse Campaign, Davis, CA 95617, USA; (N.K.H.); (T.A.W.)
| | - John D. Grewar
- Veterinary Population Management Laboratory, Faculty of Veterinary Science, University of Pretoria, Pretoria 0110, South Africa;
- JDATA, Sandbaai 7200, South Africa
| |
Collapse
|
2
|
Gupta SK. Zona pellucida glycoproteins: Relevance in fertility and development of contraceptive vaccines. Am J Reprod Immunol 2023; 89:e13535. [PMID: 35249246 DOI: 10.1111/aji.13535] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2022] [Accepted: 03/02/2022] [Indexed: 02/01/2023] Open
Abstract
Mammalian zona pellucida (ZP) is composed of three to four glycoproteins, which plays an important role during fertilization. Mutations in the genes encoding zona proteins are reported in women with empty follicle syndrome, degenerated oocytes and those with an abnormal or no ZP further emphasizing their relevance during fertility. Immunization with either native or recombinant ZP glycoproteins/proteins leads to curtailment of fertility in various animal species. Observed infertility is frequently associated with ovarian pathology characterized by follicular atresia and degenerative changes in ZP, which may be due to oophoritogenic T cell epitope(s) within ZP glycoproteins. To avoid ovarian dystrophy, B cell epitopes of ZP glycoproteins have been mapped by using bio-effective monoclonal antibodies. Immunization with the immunogens encompassing the mapped B cell epitopes by and large led to amelioration of follicular atresia. However, their use for human application will require more rigorous research to establish their safety and reversibility of the contraceptive effect. Nonetheless, to minimize human-animal conflicts, ZP-based contraceptive vaccines have been used successfully in the population management of free-ranging animal species such as feral horses, white-tailed deer and elephants. To control zoonotic diseases, attempts are also underway to control the population of other animal species including stray dogs, which acts as one of the major vectors for the rabies virus.
Collapse
Affiliation(s)
- Satish K Gupta
- Basic Medical Sciences Division, Indian Council of Medical Research, New Delhi, India
| |
Collapse
|
3
|
Segabinazzi LGTM, Gilbert RO, Ambrosia RL, Bergfelt DR, Samper JC, Peterson EW, French HM. Structural and Functional Dynamics of the Ovary and Uterus during the Estrous Cycle in Donkeys in the Eastern Caribbean. Animals (Basel) 2022; 13:ani13010074. [PMID: 36611684 PMCID: PMC9817998 DOI: 10.3390/ani13010074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2022] [Revised: 12/11/2022] [Accepted: 12/21/2022] [Indexed: 12/28/2022] Open
Abstract
Eight non-bred, non-pregnant, regularly cycling Caribbean jennies were examined daily via transrectal ultrasound to define the ovarian and uterine dynamics during four consecutive estrous cycles. Blood samples were collected every other day for progesterone analysis. The mean (±SD) overall inter-ovulatory interval across all donkeys and cycles was 22.93 ± 1.99 days. The maximum follicular diameter was 34.6 ± 2.9 mm. A two-wave pattern was evident in 97% (30/31) of the cycles. The emergence of the future dominant follicle and the largest subordinate follicle of the major primary wave coincided on Day 5.7 ± 3.6 post-ovulation, whereas the secondary wave emerged on Day 19.8 ± 2.9 during estrus of the previous cycle or early diestrus. The secondary wave was often minor (93%, 28/30 cycles). Follicular deviation occurred 8.2 ± 1.4 days before the subsequent ovulation. Luteal volume increased for the first four days after ovulation and reached a maximum volume of 8.5 ± 2.7 mm3 at Day 5.4 ± 0.4, before gradually regressing after Day 15. Serum progesterone concentration increased from Day 1 after ovulation, peaking at 27.0 ± 9.6 ng/mL between 7 and 10 days after ovulation. Progesterone concentration dropped precipitously around Day 15 after ovulation and was below 2 ng/mL around Day 17 ± 2. A day effect (p < 0.0001) was observed for corpus luteum’s volume, progesterone concentration, and uterine tone, but not for endometrial edema (p > 0.05). This study helps to clarify and define normal estrous characteristics of jennies in the Eastern Caribbean.
Collapse
|
4
|
French H, Segabinazzi L, Middlebrooks B, Peterson E, Schulman M, Roth R, Crampton M, Conan A, Marchi S, Gilbert T, Knobel D, Bertschinger H. Efficacy and Safety of Native and Recombinant Zona Pellucida Immunocontraceptive Vaccines Formulated with Non-Freund's Adjuvants in Donkeys. Vaccines (Basel) 2022; 10:1999. [PMID: 36560409 PMCID: PMC9788400 DOI: 10.3390/vaccines10121999] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2022] [Revised: 11/14/2022] [Accepted: 11/22/2022] [Indexed: 11/26/2022] Open
Abstract
This study aimed to test zona pellucida (ZP) vaccines’ immunocontraceptive efficacy and safety when formulated with non-Freund’s adjuvant (6% Pet Gel A and 500 Μg Poly(I:C)). Twenty-four jennies were randomly assigned to three treatment groups: reZP (n = 7) received three doses of recombinant ZP vaccine; pZP (n = 9) received two doses of native porcine ZP; and Control group (n = 8) received two injections of placebo. Jennies were monitored weekly via transrectal ultrasonography and blood sampling for serum progesterone profiles and anti-pZP antibody titres. In addition, adverse effects were inspected after vaccination. Thirty-five days after the last treatment, jacks were introduced to each group and rotated every 28 days. Vaccination with both pZP and reZP was associated with ovarian shutdown in 44% (4/9) and 71% (4/7) of jennies, 118 ± 33 and 91 ± 20 days after vaccination, respectively (p > 0.05). Vaccination delayed the chances of a jenny becoming pregnant (p = 0.0005; Control, 78 ± 31 days; pZP, 218 ± 69 days; reZP, 244 ± 104 days). Anti-pZP antibody titres were elevated in all vaccinated jennies compared to Control jennies (p < 0.05). In addition, only mild local injection site reactions were observed in the jennies after treatment. In conclusion, ZP vaccines formulated with non-Freund’s adjuvant effectively controlled reproduction in jennies with only minor localised side effects.
Collapse
Affiliation(s)
- Hilari French
- Department of Clinical Sciences, Ross University School of Veterinary Medicine, P.O. Box 334, Basseterre 00334, Saint Kitts and Nevis
| | - Lorenzo Segabinazzi
- Department of Clinical Sciences, Ross University School of Veterinary Medicine, P.O. Box 334, Basseterre 00334, Saint Kitts and Nevis
| | - Brittany Middlebrooks
- Department of Clinical Sciences, Ross University School of Veterinary Medicine, P.O. Box 334, Basseterre 00334, Saint Kitts and Nevis
| | - Erik Peterson
- Department of Clinical Sciences, Ross University School of Veterinary Medicine, P.O. Box 334, Basseterre 00334, Saint Kitts and Nevis
| | - Martin Schulman
- Veterinary Population Management Laboratory, Section of Reproduction, Department of Production Animal Studies, Faculty of Veterinary Science, University of Pretoria, Pretoria 0002, South Africa
| | - Robyn Roth
- Council for Scientific and Industrial Research, Pretoria 0184, South Africa
| | - Michael Crampton
- Council for Scientific and Industrial Research, Pretoria 0184, South Africa
| | - Anne Conan
- Department of Clinical Sciences, Ross University School of Veterinary Medicine, P.O. Box 334, Basseterre 00334, Saint Kitts and Nevis
| | - Silvia Marchi
- Department of Clinical Sciences, Ross University School of Veterinary Medicine, P.O. Box 334, Basseterre 00334, Saint Kitts and Nevis
| | - Trevor Gilbert
- Department of Clinical Sciences, Ross University School of Veterinary Medicine, P.O. Box 334, Basseterre 00334, Saint Kitts and Nevis
| | - Darryn Knobel
- Department of Clinical Sciences, Ross University School of Veterinary Medicine, P.O. Box 334, Basseterre 00334, Saint Kitts and Nevis
- Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Onderstepoort 0110, South Africa
| | - Henk Bertschinger
- Veterinary Population Management Laboratory, Section of Reproduction, Department of Production Animal Studies, Faculty of Veterinary Science, University of Pretoria, Pretoria 0002, South Africa
| |
Collapse
|
5
|
Gupta SK, Toor S, Minhas V, Chaudhary P, Raman M, Anoop S, Panda AK. Contraceptive efficacy of recombinant porcine zona proteins and fusion protein encompassing canine ZP3 fragment and GnRH in female beagle dogs. Am J Reprod Immunol 2022; 87:e13536. [PMID: 35249251 DOI: 10.1111/aji.13536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2021] [Revised: 01/28/2022] [Accepted: 03/02/2022] [Indexed: 11/29/2022] Open
Abstract
PROBLEM To manage population of dogs (Canis familiaris), the efficacy of recombinant proteins-based contraceptive vaccines to inhibit fertility has been evaluated in female beagle dogs. METHOD OF STUDY Female beagle dogs (n = 4) were immunized with physical mixture of Escherichia coli-expressed recombinant porcine ZP3 with promiscuous T cell epitope of tetanus toxoid (TT-KK-pZP3) and porcine ZP4 with promiscuous T cell epitope of bovine RNase (bRNase-KK-pZP4), or with a fusion protein encompassing dog ZP3 fragment and two copies of GnRH with appropriate promiscuous T cell epitopes (dZP3-GnRH2 ); control animals received only alum, the adjuvant. The immunized animals were followed-up for antibody titres by ELISA as well as for fertility status subsequent to mating with male dogs. RESULTS Active immunization of female dogs following a three injections schedule at 4-week intervals with a physical mixture of TT-KK-pZP3 + bRNase-KK-pZP4 as well as dZP3-GnRH2 , led to generation of significant antibody titres against respective recombinant proteins. Active immunization with dZP3-GnRH2 also led to generation of antibodies reactive with both dZP3 and GnRH. A booster dose on day 383 led to an increase in antibody titres and circulating antibodies against respective recombinant proteins could be observed on day 528. Antibodies in immune serum samples from dogs immunized with TT-KK-pZP3 + bRNase-KK-pZP4 or dZP3-GnRH2 reacted with native canine ZP as assessed by an indirect immunofluorescence assay. Mating studies revealed a reduced number of pregnancies as well as a significant reduction in the number of pups born in the female dogs immunized with dZP3-GnRH2 as compared to the adjuvanted control. Curtailment of pregnancy in dZP3-GnRH2 immunized group was associated with antibody titres against dZP3-GnRH2 . However, immunization with recombinant TT-KK-pZP3 + bRNase-KK-pZP4 did not significantly decrease the number of pups born as compared to the adjuvanted control. CONCLUSION These studies revealed the potential of recombinant dZP3-GnRH2 -based contraceptive vaccine to curtail fertility in female dogs. Large scale studies to establish the efficacy and safety of this recombinant protein for the management of community dog population are thus warranted.
Collapse
Affiliation(s)
- Satish K Gupta
- Reproductive Cell Biology Lab, National Institute of Immunology, New Delhi, India.,Basic Medical Sciences Division, Indian Council of Medical Research, New Delhi, India
| | - Sagarika Toor
- Reproductive Cell Biology Lab, National Institute of Immunology, New Delhi, India
| | - Vidisha Minhas
- Reproductive Cell Biology Lab, National Institute of Immunology, New Delhi, India
| | - Piyush Chaudhary
- Reproductive Cell Biology Lab, National Institute of Immunology, New Delhi, India
| | - Muthusamy Raman
- Centre for Animal Health Studies, Tamil Nadu Veterinary and Animal Sciences University, Chennai, India
| | - S Anoop
- Palamur Biosciences Private Limited, Mahabubnagar, Telangana, India
| | - Amulya K Panda
- Product Development Cell, National Institute of Immunology, New Delhi, India
| |
Collapse
|
6
|
Evaluation of Stress Accompanying Immunocontraceptive Vaccination in Donkeys. Animals (Basel) 2022; 12:ani12040457. [PMID: 35203165 PMCID: PMC8868182 DOI: 10.3390/ani12040457] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2021] [Revised: 01/11/2022] [Accepted: 01/28/2022] [Indexed: 11/29/2022] Open
Abstract
Simple Summary The overpopulation of donkeys is of concern worldwide. Some of the concerns associated with uncontrolled donkey populations are the destruction of habitat, competition for feed resources, and negative human–animal interactions. One of the most effective and humane solutions is the use of immunocontraception. Immunocontraception is the use of an animal’s immune system to prevent it from fertilizing offspring by the administration of a vaccine that targets a specific portion of the reproductive system. This study sought to measure and compare the amount of stress that is imposed when two different immunocontraceptives were administered to female donkeys. The results showed that physical exam parameters (temperature, pulse, and respiration) were not affected significantly but the measurement of stress hormones suggests an acute stress response after the first vaccination that was followed by a chronic stress response after a booster vaccination 35 days later, especially in donkeys that had reactions at the injection site. Further studies would be required to identify and reduce the stress associated with the immunocontraception vaccines that were used. Abstract The overpopulation of donkeys is recognized as a problem in many parts of the world. The main concerns with uncontrolled donkey populations are habitat degradation and competition for feed resources between donkeys and other species. One of the most effective and humane solutions is the use of immunocontraception. Therefore, this study sought to evaluate the stress imposed by the use of two formulations of a zona pellucida (ZP) vaccine, a recombinant (reZP) and a native porcine (pZP) vaccine, both formulated with a Freund’s adjuvant. The stress was objectively measured using fecal cortisol concentrations and physical examination parameters at fixed points before and after vaccination. We hypothesized that fewer changes in physical exam parameters and lower fecal cortisol concentrations would be stimulated in jennies treated with the reZP vaccine due to the selection of specific proteins. Twenty-five reproductively sound jennies were randomly assigned to reZP (n = 9), pZP (n = 8) or control (n = 8) groups. The vaccines were administered at five-week intervals. Physical exam parameters and body wall thickness of injection sites were recorded for each jenny for four days post-injections. Fecal samples were obtained every other day from day 0 (first vaccination) through day 6 and on days 35 to 41 after booster. Injection site reactions were common in all groups with the reZP and pZP groups being overrepresented. Lameness was observed in the pZP and reZP groups that were affected by injection site reactions and open abscesses. The present study showed an increase in fecal cortisol concentrations within 4 days after the first vaccination with ZP vaccines and, thereafter, a decrease in cortisol 35 days later after the second vaccination, especially in donkeys with open abscesses. Our results suggest that acute stress (increased cortisol) was induced after the first vaccination, and chronic stress (decreased cortisol) occurred thereafter in association with open abscesses. In conclusion, reZP and pZP formulated with Freund’s adjuvant induced local inflammatory reactions with a differential degree of acute and chronic stress in donkeys.
Collapse
|
7
|
Tatematsu KI, Ikeda M, Wakabayashi Y, Yamamura T, Kikuchi K, Noguchi J, Sezutsu H. Silkworm recombinant bovine zona pellucida protein 4 (bZP4) as a potential female immunocontraceptive antigen; impaired sperm-oocyte interaction and ovarian dysfunction. J Reprod Dev 2021; 67:402-406. [PMID: 34670878 PMCID: PMC8668373 DOI: 10.1262/jrd.2021-103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Porcine zona pellucida proteins (ZPs) have been utilized as female immunocontraceptive antigens. The purpose of this study was to explore the potential use of silkworm recombinant bovine ZP4 as an alternative. When the protein was injected with monophosphoryl lipid A (MPL) - an immuno-stimulative agent - into two female goats, marked elevation of the anti-ZP4 titer was detected. Application of the purified specific IgG to a porcine in vitro fertilization system reduced the sperm penetration rate. In one goat, the cyclic profile of serum progesterone disappeared as the anti-ZP4 titer increased. Histological examination of the ovaries revealed degeneration of antral follicles with sparse infiltration of inflammatory cells in the theca, indicating that autoimmune oophoritis had been induced. Together, the present results suggest that recombinant ZP4 disturbs fertilization and exerts a pathogenic effect on follicle development in goats, thus indicating its potential as a female immunocontraceptive antigen.
Collapse
Affiliation(s)
- Ken-Ichiro Tatematsu
- Division of Silk-Producing Insect Biotechnology, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization (NARO), Ibaraki 305-8634, Japan
| | - Mitsumi Ikeda
- Division of Silk-Producing Insect Biotechnology, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization (NARO), Ibaraki 305-8634, Japan
| | - Yoshihiro Wakabayashi
- Division of Advanced Feeding Technology Research, Institute of Livestock and Grassland Science, NARO, Ibaraki 305-0901, Japan
| | - Takashi Yamamura
- Division of Advanced Feeding Technology Research, Institute of Livestock and Grassland Science, NARO, Ibaraki 305-0901, Japan
| | - Kazuhiro Kikuchi
- Division of Biomaterial Sciences, Institute of Agrobiological Sciences, NARO, Ibaraki 305-8634, Japan
| | - Junko Noguchi
- New Technology Promotion Section, Strategic Planning Headquarters, NARO, Ibaraki 305-8642, Japan
| | - Hideki Sezutsu
- Division of Silk-Producing Insect Biotechnology, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization (NARO), Ibaraki 305-8634, Japan
| |
Collapse
|